Share This Page
Drug Price Trends for GNP ACETAMINOPHEN
✉ Email this page to a colleague
Average Pharmacy Cost for GNP ACETAMINOPHEN
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET | 46122-0742-68 | 0.10117 | EACH | 2025-05-21 |
| GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET | 46122-0742-68 | 0.09055 | EACH | 2025-04-23 |
| GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET | 46122-0742-68 | 0.08495 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Acetaminophen
Introduction
Acetaminophen, also known as paracetamol, is a ubiquitous over-the-counter medication used globally for pain management and fever reduction. The market for acetaminophen is influenced by a variety of factors, including demand from chronic disease management, global economic conditions, and supply chain dynamics. Here is a comprehensive analysis of the market trends and price projections for acetaminophen.
Global Market Size and Growth
The global acetaminophen market has been growing steadily, driven by increasing prevalence of chronic disorders and the need for effective pain management. As of 2022, the global market was valued at approximately $9.8 billion and is projected to reach $15.2 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.2%[4].
Regional Market Dynamics
- Asia Pacific: This region dominates the global acetaminophen market, with India and China being the largest markets. The easy availability of over-the-counter acetaminophen, increasing chronic disease burden, and growing awareness are key drivers in this region[3].
- North America: This is the second-largest regional market, driven by the rising use of medications to address opioid tolerance and the overtreatment of pain. The U.S. market is significant due to the large population of cancer patients and growing pain management awareness[4].
- Europe: Europe follows closely, with market growth influenced by the availability of affordable drugs and increasing healthcare spending.
- Latin America: This region is also experiencing rapid growth, with countries like Argentina and Brazil driving the market due to increasing healthcare spending and the availability of affordable drugs[3].
Price Trends
Recent Price Movements
In the first quarter of 2024, acetaminophen prices in North America followed a similar trajectory to those in Europe and Asia, with prices declining steadily due to global oversupply and reduced demand from international buyers. The easing of geopolitical tensions and reduced shipping costs also contributed to the downward price trend[1].
Historical Price Movements
- 2023: In the Asian markets, particularly in India, the government intervened to halt the rising prices of acetaminophen, leading to a linear downfall in its price graph. In Europe, legal battles between the government and pharmaceutical companies caused significant price oscillations[1].
- Second Half of 2022: The demand for acetaminophen in North America was low, but prices increased in the third quarter due to eased lockdown restrictions and increased export-import activities. However, prices declined in the fourth quarter due to weak economic growth and low buyer confidence[1].
Forecast and Analyst Insights
Price Projections
Analysts predict that the price trend of acetaminophen will follow a weak trend in the upcoming quarters due to slow arrival of downstream orders and challenging global trading dynamics. However, in Asian countries, prices are expected to surge in the forthcoming quarter due to announcements by regulatory bodies like the NPPA[1].
Market Growth Drivers
- Increasing Chronic Disorders: The growing prevalence of chronic diseases such as cancer and chronic obstructive pulmonary disease (COPD) is driving the demand for acetaminophen[4].
- Opioid Tolerance: The need for alternative pain management solutions due to opioid tolerance is another significant driver[4].
- Geriatric Population: Emerging markets with increasing geriatric populations, such as China and India, are expected to bring new growth opportunities[3].
Challenges and Restraints
- Global Economic Conditions: Weak global economic conditions, including recession fears, inflation, and interest rate hikes, can impact demand and pricing[1].
- Competition and Generics: The availability of a large number of generic alternatives and intense competition may restrain market growth[3].
Key Market Players
The acetaminophen market is led by several major players, including:
- Genesis Biotech
- M.M. Pharma
- Aknil biotech
- Arika healthcare
- Captab biotech
- GlaxoSmithKline Pharmaceuticals Ltd.
- Pfizer Inc.
- Sanofi
- Janssen Pharmaceuticals
- Bayer AG[3][4].
Market Segmentation
The acetaminophen market is segmented based on form, indication, route of administration, and region. The oral route of administration dominates the market, with a share of about 92.4% as of 2022[4].
Conclusion
The acetaminophen market is poised for steady growth driven by increasing demand for pain management solutions, particularly in regions with growing geriatric populations and rising chronic disease burdens. However, the market faces challenges from global economic conditions, competition from generics, and fluctuations in raw material costs.
Key Takeaways
- The global acetaminophen market is expected to grow at a CAGR of 4.2% from 2024 to 2033.
- Asia Pacific, led by India and China, dominates the global market.
- Increasing chronic disorders and opioid tolerance are key drivers of demand.
- Global economic conditions and competition from generics are significant restraints.
- The oral route of administration is the leading segment in the market.
FAQs
Q: What is the projected global market value of acetaminophen by 2033? A: The global acetaminophen market is projected to reach a valuation of $15.2 billion by 2033[4].
Q: Which region dominates the global acetaminophen market? A: The Asia Pacific region, particularly India and China, dominates the global acetaminophen market[3].
Q: What are the main drivers of demand for acetaminophen? A: The main drivers include increasing chronic disorders, opioid tolerance, and the need for effective pain management solutions[4].
Q: How does the global economic condition impact the acetaminophen market? A: Weak global economic conditions, such as recession fears, inflation, and interest rate hikes, can impact demand and pricing of acetaminophen[1].
Q: Which companies are the key players in the acetaminophen market? A: Key players include Genesis Biotech, M.M. Pharma, Aknil biotech, Arika healthcare, Captab biotech, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Inc., Sanofi, Janssen Pharmaceuticals, and Bayer AG[3][4].
Sources
- Procurement Resource - Acetaminophen Price Trend and Forecast[1]
- 24 Chemical Research - Global Acetaminophen Forecast Market 2023-2030[2]
- Zion Market Research - Acetaminophen (Paracetamol) Market Size, Share, Trends, and Forecast[3]
- Future Market Insights - Acetaminophen Market Size, Share, Trends & Outlook - 2033[4]
- Persistence Market Research - Acetaminophen Market Size, Share & Growth Analysis, 2031[5]
More… ↓
